Lumida
/DSGN
⌘K
Design Therapeutics Inc

Design Therapeutics Inc

DSGN
$15.11USD-0.92%-0.14 today

MARKET CAP

950.6M

P/E (TTM)

FWD P/E

DAY RANGE

$15 – $15

52W RANGE

$5
$17

AI Summary

Stalk
Buy NowHigh

In a Stage 2 advancing corrective reset within a broader uptrend, active Lockout Rally dynamics and sustained EMA support justify immediate bullish participation despite overbought readings, focusing on pullbacks into rising EMA confluence near the prior breakout zone.

  • Phase I DT216 delivers significant endogenous frataxin mRNA boost
  • $303 M cash balance supports clinical data in up to four programs through 2026
  • Injection-site thrombophlebitis halts dose escalation and delays trials
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %